Target intelligence / Profile preview

Ribosomal protein L29 pseudogene 25 (RPL29P25)

Target
RPL29P25
Molecular classification
Other
01

Overview

Ribosomal protein L29 pseudogene 25 (RPL29P25) is a processed pseudogene in the human genome. It does not code for a functional protein. This pseudogene is one of several genomic loci that share high sequence similarity with the functional ribosomal protein L29 (RPL29) gene, which encodes a component of the large (60S) ribosomal subunit responsible for protein synthesis. Like other processed pseudogenes, RPL29P25 likely arose from retrotransposition and is regarded as non-functional, having no documented biological function, disease association, molecular action, or role as a therapeutic target[1][2][5]. This entry is not a protein, receptor, enzyme, or druggable molecular target. It is a genetically inactive pseudogene, included as genomic background but not relevant for pharmacological or therapeutic applications[1][2][5]. The functional version is "Ribosomal protein L29" (RPL29), a ribosomal structural protein, but RPL29P25 itself does not produce protein or exert biological effects[1][5].

Other names
RPL29P25

Beyond the preview

Go deeper on Ribosomal protein L29 pseudogene 25 (RPL29P25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L29 pseudogene 25 (RPL29P25).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call